Skip to Content


Active Substance: sulesomab
Common Name: sulesomab
ATC Code: V04D
Marketing Authorisation Holder: Immunomedics GmbH
Active Substance: sulesomab
Status: Withdrawn
Authorisation Date: 1997-02-14
Therapeutic Area: Radionuclide Imaging Osteomyelitis
Pharmacotherapeutic Group: Diagnostic agents

Therapeutic Indication

This medicinal product is for diagnostic use only.

LeukoScan is indicated for diagnostic imaging for determining the location and extent of infection/inflammation in bone in patients with suspected osteomyelitis, including patients with diabetic foot ulcers.

LeukoScan has not been employed to diagnose osteomyelitis in patients with sickle cell anaemia.

The marketing authorisation for LeukoScan has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.